New nanoparticles deliver therapy throughout the brain and edit Alzheimer's gene in mice12 ViewsLikes 0
Eli Lilly's Alzheimer’s drug ‘donanemab’ fails to get early FDA approval (20 Jan. 2023)9 ViewsLikes 0
AI-powered analysis accurately reflects risk of cognitive decline and Alzheimer’s disease based on brain age, with an average absolute error of 2.3 years, which is about one year more accurate than an existing, award-winning model for brain age estimation15 ViewsLikes 0
